Rapid Micro Biosystems RPID Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -141.1%+36.9pp | -178%+73.2pp | -251.2%+118pp | -369%-166pp | |
| Net margin | -140.3%+26.9pp | -167.2%+65.8pp | -233%+122pp | -354.9%-38.4pp | |
| Returns | |||||
| Return on equity | -86.8%-38.3pp | -48.5%-11.3pp | -37.2%-5.6pp | -31.6%— | |
| Return on invested capital | -93.7%-33.3pp | -60.5%-14.4pp | -46.1%— | —— | |
| Efficiency | |||||
| Asset turnover | 0.4×+0.2× | 0.2×+0.1× | 0.1×+0.1× | 0.1×-0.1× | |
| Liquidity | |||||
| Current ratio | 3.3×-1.3× | 4.6×-1.7× | 6.3×-0.9× | 7.3×-4.7× | |
| Leverage | |||||
| Debt-to-equity | 0.7×+0.6× | 0.1×0.0× | 0.1×0.0× | 0×— | |
| Per Share | |||||
| Book value per share | $0.74-57.0% | $1.73-36.9% | $2.74-29.1% | $3.87-65.4% | |
| Valuation | |||||
| Market capitalization | $86.19M-43.5% | $38.73M+23.4% | $31.38M-33.9% | $47.45M-89.2% | |
| Price / sales | 2.5×-2.5× | 1.4×0.0× | 1.4×-1.4× | 2.8×-16.2× | |
| Price / book | 4.2×+1.4× | 0.5×+0.2× | 0.3×0.0× | 0.3×-1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Rapid Micro Biosystems's ratios come from?
- Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
